{"id":"NCT05259917","sponsor":"KalVista Pharmaceuticals, Ltd.","briefTitle":"A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Three-way Crossover Trial to Evaluate the Efficacy and Safety of Two Dose Levels of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema Type I or II","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-02-22","primaryCompletion":"2023-12-31","completion":"2023-12-31","firstPosted":"2022-03-02","resultsPosted":"2024-07-19","lastUpdate":"2025-05-02"},"enrollment":136,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Angioedema"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"KVD900 600 mg","otherNames":[]},{"type":"DRUG","name":"KVD900 300 mg","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"KVD900 600 mg","type":"EXPERIMENTAL"},{"label":"KVD900 300 mg","type":"EXPERIMENTAL"}],"summary":"This study is a randomized, double-blind, placebo-controlled, phase III, three-way crossover clinical trial evaluating the efficacy and safety of KVD900, in the treatment of hereditary angioedema attacks in adolescent and adult Patients","primaryOutcome":{"measure":"Time to Beginning of Symptom Relief Patient Global Impression of Change (PGI-C)","timeFrame":"Within 12 hours of the first investigational medicinal product (IMP) administration.","effectByArm":[{"arm":"KVD900 300 mg","deltaMin":1.61,"sd":null},{"arm":"KVD900 600 mg","deltaMin":1.79,"sd":null},{"arm":"Placebo","deltaMin":6.72,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"0.0013"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":13},"locations":{"siteCount":66,"countries":["United States","Australia","Bulgaria","Canada","France","Germany","Greece","Hungary","Israel","Italy","Japan","Netherlands","New Zealand","North Macedonia","Poland","Portugal","Puerto Rico","Romania","Slovakia","Spain","United Kingdom"]},"refs":{"pmids":["38819658","40886933","36774155"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":86},"commonTop":["HEADACHE","VOMITING","NAUSEA","FATIGUE","EYE HAEMORRHAGE"]}}